Outlook Therapeutics (OTLK) Interest Coverage Ratio (QoQ) (2015 - 2023)
Outlook Therapeutics (OTLK) Interest Coverage Ratio (QoQ) (2015 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Outlook Therapeutics |
86.15 Mn |
78.40 Mn |
-21,888.00 |
| Date | Value |
|---|
| Sep 30, 2023 |
-1.02% |
| Mar 31, 2021 |
43.27% |
| Dec 31, 2020 |
83.11% |
| Sep 30, 2020 |
-1,865.00% |
| Jun 30, 2020 |
-175.61% |
| Mar 31, 2020 |
29.05% |
| Dec 31, 2019 |
77.32% |
| Sep 30, 2019 |
-1,057.36% |
| Jun 30, 2019 |
28.64% |
| Mar 31, 2019 |
20.10% |
| Dec 31, 2018 |
-158.16% |
| Sep 30, 2018 |
350.07% |
| Jun 30, 2018 |
15.17% |
| Mar 31, 2018 |
-67.47% |
| Dec 31, 2017 |
-226.77% |
| Sep 30, 2017 |
67.75% |
| Jun 30, 2017 |
33.30% |
| Mar 31, 2017 |
82.68% |
| Dec 31, 2016 |
-124.98% |
| Sep 30, 2016 |
78.02% |
